NCT02161939|Unknown
Loading search results
Sponsor study identifier
expanded_access
N/A
1 country
20
Study Start
Not reported
Date not reportedPrimary Completion
Not reported
Date not reportedStudy Completion
Not reported
Date not reportedThe primary objective of this program is to provide DCV for 24 weeks to be given in combination with SOF to subjects with chronic hepatitis C with decompensated cirrhosis or post-liver transplant subjects with chronic hepatitis C recurrence with either advanced fibrosis or fibrosing cholestatic hepatitis and who have a serious or immediately life-threatening condition or experienced an event that has decreased their life expectancy to \<12 months, therefore, no research hypothesis will be tested and no specific endpoints are defined. However, safety data will be collected throughout the study as well as efficacy data
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 10, 2014
Actual (reported)June 12, 2014
Actual (reported)Mayo Clinic
Phoenix, Arizona, 85054, United States
USC - Keck Medical Center
Los Angeles, California, 90033, United States
Yale University School of Medicine
New Haven, Connecticut, 06520, United States
University of Florida
Gainesville, Florida, 32610, United States
Piedmont Transplant
Atlanta, Georgia, 30309, United States
Indiana University
Indianapolis, Indiana, 46202, United States
Ochsner Clinic Foundation
New Orleans, Louisiana, 70121, United States
Bristol-Myers Squibb
Bristol-Myers Squibb
First Submitted
June 10, 2014
First Posted
June 12, 2014
Last Updated
January 29, 2016
Record last verified: 2016-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Contact the study team to confirm eligibility.
Mercy Medical Center, Inc.
Baltimore, Maryland, 21202, United States
Mass General
Boston, Massachusetts, 02114, United States
University of Massachusetts Memorial Medical Center, University Campus
Worchester, Massachusetts, 01655, United States
Henry Ford
Detroit, Michigan, 48202, United States
Weill Cornell Medical College
New York, New York, 10021, United States
Columbia University Medical Center
New York, New York, 10032, United States
Montefiore Medical Center
The Bronx, New York, 10467, United States
UNC
Chapel Hill, North Carolina, 27599, United States
Carolinas Healthcare Institute
Charlotte, North Carolina, 28204, United States
University of Pennsylvania
Philadephia, Pennsylvania, 19104, United States
Research Specialist of Texas
Houston, Texas, 77030, United States
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
Swedish Hospital
Seattle, Washington, 98122, United States